Injectable and pH‐Activated Self‐Feedback Hydrogel Encapsulating Stem Cells for Augmented Acute Myocardial Infarction Therapy
Advanced Healthcare Materials · 2026-02 · 15 (5)
DOI: 10.1002/adhm.202503324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 23.10.2025. Verfasst von Yan Kong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy, Naval Medical University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Hydrogels, Stem Cells, Stem Cell Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Shanghai Industrial Collaborative Innovation Project.
Abstract (Originalsprache)
Hydrogels encapsulating stem cells represent a promising strategy for enhancing cardiac function following acute myocardial infarction (AMI). However, hostile post‐infarct microenvironments, characterized by oxidative stress and ischemia, significantly reduce stem cell retention and survival rates. Herein, an intramyocardially injectable and pH‐responsive (2′ Z, 3′ E)‐6‐Bromoindirubin‐3′‐oxime (BIO)‐N‐adipose‐derived stem cells (ADSCs)‐Matrigel system is developed for treating AMI. Encapsulated ADSCs exhibited a high retention rate in myocardial tissue. Furthermore, BIO‐N exhibited a self‐feedback function, enabling it to modulate the release of BIO in response to pH changes in the microenvironment during the progression of AMI. This system effectively protected stem cells and cardiomyocytes from ROS‐induced injury while enhancing the therapeutic efficacy of ADSCs by improving their paracrine function. Subsequently, it is demonstrated that the BIO‐N‐ADSCs‐Matrigel system significantly reduced infarction size, mitigated fibrosis, and enhanced local angiogenesis in a rat model of AMI. The self‐feedback functional BIO‐N‐ADSCs‐Matrigel system can effectively mitigate local oxidative stress, enhance the survival rate and therapeutic efficacy of stem cells, and improve the viability of cardiomyocytes for AMI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Anatomy, Naval Medical University, Shanghai, 200433, China.
- Department of Anatomy, Anhui Medical University, Anhui, 230032, China.
- Department of Nanomedicine, Translational Medicine Research Center & Shanghai Key Laboratory of Nautical Medicine and Translation of Drugs and Medical Devices, Naval Medical University, Shanghai, 200433, China.
ORCID-Profile: Wei Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Shanghai Industrial Collaborative Innovation Project
- Shanghai Outstanding Academic Leaders
- Yizhang Talent Cultivation Program of Basic Medical College in Naval Medical University
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Kong, Y., Wang, L., Duan, F., Huang, C., Qiu, Z., Ji, R. J., Qiao, L., Zhou, Y., Cai, T., Li, Y. Q., Li, W., & Yang, X. Q. (2026). Injectable and pH‐Activated Self‐Feedback Hydrogel Encapsulating Stem Cells for Augmented Acute Myocardial Infarction Therapy. Advanced Healthcare Materials, 15(5). https://doi.org/10.1002/adhm.202503324
Vancouver
Kong Y, Wang L, Duan F, Huang C, Qiu Z, Ji RJ, et al. Injectable and pH‐Activated Self‐Feedback Hydrogel Encapsulating Stem Cells for Augmented Acute Myocardial Infarction Therapy. Advanced Healthcare Materials. 2026;15(5). doi:10.1002/adhm.202503324
BibTeX
@article{Kong2026,
author = {Kong, Yan and Wang, Ling and Duan, Fei and Huang, Chao and Qiu, Zhiwen and Ji, Rui-Juan and Qiao, Liang and Zhou, Yang and Cai, Ting and Li, Yu-Quan and Li, Wei and Yang, Xiang-Qun},
title = {Injectable and pH‐Activated Self‐Feedback Hydrogel Encapsulating Stem Cells for Augmented Acute Myocardial Infarction Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {5},
doi = {10.1002/adhm.202503324}
}
EUVIMED